Regulus Therapeutics Inc (RGLS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RGLS Annual Balance Sheets →
Examining balance sheet movements between Regulus Therapeutics Inc and Mar 31 2024 reveals how Mar 31 2025 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent49.46
Short-term Investments, Total15.91
Cash & Short-term Investments64.00
Other Current Assets2.86
Prepaid Expense, Current AS3.47
Total Current Assets71.69
Equipment/Property/Plant Net1.12
Intangible Assets0.02
Long-term investments0.00
Other Assets, Noncurrent0.00
Restricted Cash0.06
Operating Lease Right Of Use Asset1.99
Total Assets74.83
Liabilities
Accounts Payable, Current AC0.20
Accrued Liabilities, Current2.25
Debt, Current LI0.00
Other Liabilities, Current1.95
Total Current Liabilities4.40
Total Long-term Debt0.00
Other liabilities, Noncurrent1.40
OperatingLeaseLiabilityNoncurrent1.40
Accrued Research And Development Current1.15
Total Liabilities5.80
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock638.15
Retained Earnings / Accumulated Deficit-569.21
Other Equity0.02
Common Stockholder's Equity69.03
Preferred Stockholder's Equity0.00
Total Stockholder's Equity69.03
Liabilities & Stockholder's Equity74.83
4 historic quarters locked

Sign in to unlock the full Regulus Therapeutics Inc balance sheet history.

About Regulus Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-25-023872

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.